Compared with the other cancer types, familial breast cancer was less likely to have an additional somatic or germline mutations accompanying a germline PALB2 mutation (6/10 vs. 18/18, Fisher’s exact test, p = 0.02; Table 3). This evidence concerns the gene PALB2 and breast cancer.